Peptides for Men Over 40: CJC-1295, Ipamorelin & NAD+ Research

After age 40, men experience several well-documented biological changes that drive interest in peptide research:

Growth hormone decline: GH production falls approximately 14% per decade from age 30. By 50, most men produce 30-40% less GH than their 25-year-old baseline.

NAD+ depletion: NAD+ levels drop approximately 50% between ages 40 and 60, impairing mitochondrial function, DNA repair, and sirtuin activity.

Testosterone decline: Testosterone decreases 1-2% annually from age 30, affecting muscle mass, bone density, mood, and body composition.

Recovery capacity: Tissue repair slows, injuries take longer to heal, and exercise recovery becomes more prolonged.

Body composition shifts: Increasing visceral fat, decreasing lean muscle mass, and reduced metabolic rate.

Peptides offer a research avenue distinct from hormone replacement therapy — targeting the body's own signalling systems rather than directly replacing hormones. This guide reviews the peptides most studied in the context of male ageing.

The CJC-1295 and Ipamorelin combination is the most popular peptide protocol for men researching GH optimisation:

CJC-1295 (GHRH receptor agonist): - Stimulates the pituitary to produce growth hormone - Extends the GH production window - Promotes IGF-1 elevation - Half-life: ~30 minutes

Ipamorelin (Ghrelin receptor agonist): - Triggers sharp, pulsatile GH release - Highly selective — does not increase cortisol or prolactin - Mimics natural nocturnal GH pulse patterns - Synergistic with GHRH agonists

Research-relevant outcomes studied: - Body composition: Reduced visceral adiposity and improved lean mass in GH-deficient models - Sleep architecture: Enhanced slow-wave (deep) sleep — GH is primarily released during deep sleep - Recovery: Improved tissue repair rates associated with optimised GH levels - Bone density: GH stimulates osteoblast activity, relevant to age-related bone loss in men - Skin thickness: GH promotes collagen synthesis and dermal thickness

Administration research protocols: Published protocols typically study evening administration (30-60 minutes before sleep, fasted) to align with the body's natural nocturnal GH peak.

Peptides Pharma offers both as 30-day Research Vials: CJC-1295 (€109) and Ipamorelin (€109). The combined €218 order qualifies for free UK shipping.

NAD+ addresses the most fundamental mechanism of cellular ageing — energy production and DNA repair:

Why NAD+ matters for men over 40:

*Mitochondrial function*: NAD+ is essential for the electron transport chain — the cellular engine that produces ATP (energy). Declining NAD+ = declining cellular energy output. This manifests as reduced physical endurance, slower recovery, and general fatigue.

*Sirtuin activation*: SIRT1-SIRT7 (the 'longevity enzymes') require NAD+ as a cofactor. These enzymes regulate inflammation, fat metabolism, stress resistance, and circadian rhythms. Low NAD+ = impaired sirtuin function across all seven enzymes.

*DNA repair*: PARP enzymes require NAD+ to repair DNA strand breaks. Men over 40 accumulate more DNA damage while having less NAD+ to fund repair — a compounding deficit.

*Testosterone-related research*: Emerging studies suggest NAD+ influences testicular function and spermatogenesis through sirtuin-mediated pathways. This is a developing area of research.

Why injectable vs oral NMN/NR? Oral NAD+ precursors must undergo enzymatic conversion (NMN → NAD+ or NR → NMN → NAD+), with variable efficiency. Peptides Pharma's injectable NAD+ bypasses these conversion steps entirely.

- Peptides Pharma NAD+ Research Vial: €189 (30-day supply) - Peptides Pharma NAD+ Vial: €299 (advanced cartridge system for precision microdosing)

Men over 40 who maintain active lifestyles — gym training, sports, manual work — frequently experience slower recovery and increased injury rates. BPC-157 and TB-500 address different aspects of this:

BPC-157 for men over 40: - Tendon and ligament healing (the most common injury type in this demographic) - Joint tissue support relevant to osteoarthritis research - Gut health — gastric protection, anti-inflammatory effects - Muscle repair — accelerated recovery from exercise-induced damage

TB-500 for men over 40: - Anti-fibrotic properties — promoting clean tissue healing over scar formation - Angiogenesis — new blood vessel formation to support tissue perfusion - Cardiac tissue research — relevant given cardiovascular risk increases in men over 40 - Cell migration — supporting the body's repair cell deployment

The recovery stack: BPC-157 (€119) + TB-500 (€119) = €238 for 60 days of dual-peptide recovery research. Free UK shipping included.

This is the most popular peptide combination among male researchers over 40 in the UK, addressing the musculoskeletal recovery challenges that define this demographic's primary research interest.

Based on published research, a multi-target protocol for men over 40 might include:

Tier 1 — Foundational (pick one): - NAD+ for cellular energy and DNA repair (€189-€299) - CJC-1295 + Ipamorelin for GH optimisation (€218)

Tier 2 — Recovery (if active/injured): - BPC-157 + TB-500 for tissue repair (€238) - BPC-157 alone for general recovery (€119)

Tier 3 — Advanced (comprehensive protocol): - Add GHK-Cu (€139) for skin, hair, and collagen research - Add Glutathione (€99) for antioxidant defence

Popular combinations by budget: - Budget: CJC-1295 + Ipamorelin = €218/month (GH optimisation) - Mid-range: NAD+ + BPC-157 = €308-€408/month (cellular energy + recovery) - Comprehensive: CJC + Ipamorelin + BPC-157 + NAD+ = €526-€636/month

Volume discounts: Peptides Pharma offers 5% off for 3-5 units, 10% off for 6-9 units, and 15% off for 10+ units — making comprehensive protocols more affordable.

All Peptides Pharma research vials provide 30-day supplies, making protocol coordination straightforward. Free UK shipping applies to orders over €175.